Priority Review of Drug Submissions (Therapeutic Products)

Name: Priority Review of Drug Submissions (Therapeutic Products)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review and approval of a request submitted by the sponsor of the drug. Priority Review submissions are introduced into Health Canada's drug review queue in accordance with an accelerated review target of 180 days.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-03

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Priority Review of Drug Submissions (Therapeutic Products) (French, HTML) HTML
Priority Review of Drug Submissions (Therapeutic Products) (English, HTML) HTML

Related open data

Health Canada